Sales and Marketing

Showing 15 posts of 11528 posts found.

Intelligent Automation in Pharmacovigilance

November 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, pharmacovigilance, primevigilance

PrimeVigilance is pleased to announce their collaboration with the International Society of Pharmacovigilance (ISoP) on the upcoming seminar, organised by …

Recipharm equips a further three facilities for US serialisation

November 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped three more of its facilities with serialisation capabilities in …

Veeva European Commercial & Medical Summit

November 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, veeva

The Veeva European Commercial & Medical Summit will begin tomorrow, seeing more than 800 industry leaders convene at the Marriot …

The global HIV/AIDS movement

November 27, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AIDS, HIV, International HIV/AIDS Alliance

Increasingly collaborative efforts have seen the threat of HIV recede and brought hope to demographics and communities most vulnerable to …

Bayer’s $175 million pneumonia drug fails at phase 3

November 27, 2017 Research and Development, Sales and Marketing Amikacin, Amikacin Inhale, Bayer, Nektar Therapeutics, pharma

Bayer has been hit by the news that its latest effort in the pneumonia space failed at the Phase 3 …

AstraZeneca continues pivot to east with Chinese collaboration

November 27, 2017 Medical Communications, Sales and Marketing AstraZeneca, biotech, drugs, pharma, pharmaceutical

It’s been a rocky year for AstraZeneca, it has scored some major successes yet its year has been marred by …

Proposed cuts to National Institutes of Health could delay up to 90% of US drug approvals

November 27, 2017 Research and Development, Sales and Marketing Donald Trump, FDA, NIH, National Institutes of Health, Trump, pharma

President Donald Trump’s budget proposes to cut funding to the National Institutes of Health by $7.2 billion or 21%. Researchers …

UK government unveils pharma research HQ coup

November 27, 2017 Medical Communications, Sales and Marketing MSD, biotech, drugs, life sciences, pharma, pharmaceutical

The UK government’s Autumn Budget struck a gloomy note for the economy, with figures pointing towards low productivity and the …

Top Ten most popular articles on Pharmafile.com this week

November 24, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

As Friday comes round again, this week saw some of the biggest news of the year: Amsterdam is the new …

Learning lessons from HIV to change the treatment access landscape

November 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, HIV, pharma

Greg Alton, Executive Vice President of Corporate and Medical Affairs at Gilead, reveals how the rapid development and distribution of …

Tesaro secures EU approval in specific ovarian cancer population

November 23, 2017 Sales and Marketing Europe, European Commission, Tesaro, Zejula, pharma

The European Commission has granted Tesaro’s Zejula (niraparib) marketing approval in Europe, it has emerged.  Zejula is a poly (ADP-ribose) …

Collaboration in Biopharma

November 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dear Colleague, Biopharmaceutical companies are increasingly partnering with a diverse set of health care stakeholders to address scientific and technological …

FDA approves first-ever two-drug HIV regimen, GSK’s Juluca

November 22, 2017 Research and Development, Sales and Marketing AIDS, FDA, GSK, Gilead, GlaxoSmithKilne, HIV, Juluca, ViiV Healthcare, pharma

GlaxoSmithKline has announced that the FDA has awarded US marketing authorisation to the first two-drug regimen in the treatment of …

EU approves opioid treatment, amid fears of US-like crisis

November 22, 2017 Research and Development, Sales and Marketing Zubsolv, biotech, drugs, opioid, orexo, pharma, pharmaceutical

The EMA has given approval for the treatment of Orexo’s Zubsolv, a therapy for the treatment of opioid dependence. The …

Free Webinar: The End Game – Payer Engagement

November 21, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, pharma, pharmaceutical

In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …
The Gateway to Local Adoption Series

Latest content